Table 3.
Comparison of clinical data between patients with and without diabetic neuropathy.
| With diabetic neuropathy | Without diabetic neuropathy | p-Value | |
|---|---|---|---|
| Age (years) | 64.2 (13.1) | 66.1 (11.4) | 0.057 |
| Duration of diabetes (years) | 17.4 (10.1) | 14.5 (9.7) | <0.001 |
| Sex (male/female) | 121/90 | 337/192 | 0.11 |
| Height (cm) | 161 (9.7) | 161.1 (8.8) | 0.93 |
| Weight (kg) | 63.3 (14.1) | 62.5 (13.1) | 0.42 |
| BMI (kg/m2) | 24.4 (4.8) | 23.9 (3.7) | 0.22 |
| Brinkman index | 841 (572) | 821 (539) | 0.82 |
| Systolic blood pressure (mmHg) | 130 (18) | 128.5 (16.9) | 0.28 |
| Diastolic blood pressure (mmHg) | 70.2 (11.3) | 70.8 (9.9) | 0.53 |
| Plasma glucose (mg/dl) | 184.6 (82.8) | 161.5 (63.1) | <0.001 |
| Plasma HbA1c (%) | 8.4 (1.7) | 7.6 (1.3) | <0.001 |
| Total cholesterol (mg/dl) | 194 (38) | 199 (34) | 0.14 |
| Triglycerides (mg/dl) | 152.6 (105.3) | 146.7 (102.1) | 0.49 |
| HDL cholesterol (mg/dl) | 51.6 (16.6) | 52.3 (14.6) | 0.57 |
| LDL cholesterol (mg/dl) | 110.1 (30.9) | 113.7 (29) | 0.14 |
| Urinary albumin creatinine ratio (mg/gCr) | 53.7 (64.9) | 33 (50.6) | 0.003 |
| CVRR | 2.28 (1.12) | 2.83 (1.35) | 0.12 |
| ABI | 1.12 (0.15) | 1.16 (0.09) | 0.005 |
| TBI | 0.71 (0.17) | 0.78 (0.16) | <0.001 |
| baPWV (cm/s) | 1,828 (423) | 1,758 (347) | 0.13 |
| SNCV (m/s) | 40.9 (14.8) | 53.9 (4.3) | <0.001 |
| SNAP (μV) | 5.9 (5.1) | 11.9 (6.4) | <0.001 |
Values are expressed as means (SD) except for sex.
BMI, body mass index; HbA1c, hemoglobin A1c; HDL, high-density lipoprotein; LDL, low-density lipoprotein; CVRR, coefficient of variation of R–R intervals; ABI, ankle–brachial index; TBI, toe–brachial index; baPWV, brachial–ankle pulse wave velocity; SNCV, sural nerve conduction velocity; SNAP, sural nerve amplitude.